Delivery Order SPE2DB20D2014-SPE2DB24FC98R
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $12,548 delivery order contract to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 pharmaceutical syringes. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a firm...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The $9,657.91 firm-fixed-price contract has an ultimate completion date of August 21, 2024. This order is a part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $47,098.12 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4564804564 - GARDASIL 9 SYRINGE 0.5ML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $9,761.55 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,684,229 units of GARDASIL 9 vaccine syringes (0.5 mL) with a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract worth $3,021.74 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565740423 GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of...
This is a $5,527.64 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with an ultimate completion date of July 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to...
This is a $32,096.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 vaccine syringes. The contract has a period of performance through February 4, 2025 and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of GARDASIL 9 SYRINGE 0.5ML. The $4,705.50 firm fixed-price contract has a completion date of May 23, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,616.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a $11,339.92 firm-fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of GARDASIL 9 SYRINGE 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. Amerisourcebergen, a major pharmaceutical distributor, has been providing...